Work

Durable Responses to Lenalidomide (Revlimid®) in Patients with AL Amyloidosis: Follow Up of a Phase II Trial.

Year: 2007

Type: article

Source: Blood

DOI: 10.1182/blood.v110.11.192.192

Authors: David C. Seldin, Michael Rosenzweig, Kathleen T. Finn, Salli Fennessey, Anthony Shelton, Jerome B. Zeldis, Martha Skinner, Vaishali Sanchorawala

Institutions: Boston University, Boston Medical Center, Celgene (United States)

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2535478099

FWCI: 0.395

Cites:

Cited by: 3

Related to: 10